AIMR 23 Pulmonary Medicine Series

Current Status
Not Enrolled
Price
Closed
Get Started
This course is currently closed

This course will not be visible to you until you log in using the BLUE login button.  It will say "CLOSED."  If you have registered for this series, use your ACPNJ CME system login using the blue LOGIN button to access all materials.  

ANNUAL INTERNAL MEDICINE REVIEW SERIES
PART TWO - Pulmonary Medicine - 2023

 

Join our master faculty for a six-hour webinar course spread across three two-hour sessions  where you will learn about major clinical topics in the field of Rheumatology.  This course will be beneficial to all Internal Medicine physicians who are seeking to improve their care for pulmonary patients.

SERIES SCHEDULE:

Session 1 Wednesday, August 23, 2023

Session 2 Wednesday, August 30, 2023

Session 3 Wednesday, September 6, 2023

 

Instructions

  • This course will not be visible to you until you log in using the BLUE login button.  It will say "CLOSED."  Use your ACPNJ CME system login using the blue LOGIN button to access all materials.  
  • Please complete the post-test  for each of the three Pulmonary Medicine Series sessions you attend.  You can find them listed under "Course Content" both at the bottom of this page and in the shaded box on the right side of the page.  CLICK THE APPROPRIATE SESSION TO BEGIN. Note: post-tests will not become available until after the corresponding session has been completed.  
  • FINAL EVALUATION AND CLAIM FOR CREDIT will be available after the conclusion of the third series session, September 6, 2023.
  • If you wish to claim MOC credit, you will be required to add your ABIM ID number, License Number and Birthday (Month and Day) to the final claim for credit form.
  • Please do not claim credit for a session you did not attend.
  • You must be logged in to this activity to participate and claim credit.
  • You must score of 80% to complete each session post-test.
  • Your CME certificate will use the name and credentials in your profile.
    • Please ensure that your profile is up-to-date and correct, including first and last names and professional credentials.   
    • If you need to edit your profile, click the "Edit Your Profile" button.  You will be returned to this page when you have saved your new information.

FACULTY

James Prister, MD
Associate Program Director,
Internal Medicine Residency Program
Rutgers RWJ Medical School
New Brunswick, NJ

DISCLOSURE

Dr. James Prister, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.

The planners, reviewers, and others in control of content have no relevant financial relationships with ineligible companies.

Course Content

Click the appropriate session listed below to begin.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the New Jersey Academy of Family Physicians and the American College of Physicians New Jersey Chapter. The New Jersey Academy of Family Physicians is accredited by the ACCME to provide continuing medical education for physicians.

The New Jersey Academy of Family Physicians designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning Objectives

1. Describe common pulmonary tests
2. Discuss common pulmonary diseases
3. Discuss updates in the treatment of lung cancer, interstitial lung disease, and pulmonary hypertension